Endocrinology and Metabolic Disorders

Stephen Safe is a Distinguished Professor of Toxicology, Department of Veterinary Physiology and Pharmacology at Texas A&M University. Safe has conducted major research into the anti-estrogenic effects of manmade chemicals. He has been a leading critic of the endocrine disruption hypothesis espoused by Theo Colborn and others.

Dr. Safe's research is focused on the molecular biology of cancer cell growth and development of new mechanism-based anticancer drugs, with emphasis in the areas of molecular biology of endocrine disruption chemicals, mechanisms of toxicity, breast cancer including mechanisms and therapeutics, pancreatic, prostate, colon, and bladder cancer including mechanisms of growth and effects of PPARyagonists.

Dr. Weiqin Chen studied the role of dyslipidemia on diabetic retinopathy, a microvascular complication in diabetic patients with Dr. Julia Busik at Michigan State University and received her PhD degree in Molecular Genetics in 2005. Subsequently, she worked as a Postdoctoral associate for five years with Dr. Lawrence Chan at Baylor College of Medicine, where she was promoted as an instructor in 2010. At BCM, she established two animal models based on genes that are associated with non-alchoholic fatty liver disease (NALFD) and human congenital generalized lipodystrophy (CGL) and characterized their functions in energy metabolism. In 2012, she was recruited as an Assistant Professor in the Department of Physiology at Georgia Regents University. The focus of her current research is to dissect the mechanisms underlying adipose tissue dysfunction and development of obesity and lipodystrophy using both in vivo and in vitro strategies.

besity and its associated health comorbidities are a worldwide epidemic with serious economic and health burden on society. Adipose tissue is an important endocrine organ that plays a key role in the development of obesity and various metabolic disorders. White adipocytes store excess energy in the form of triglycerides for future need. By contrast, brown and beige (browning-in-white) adipocytes metabolize lipid and glucose to produce heat in a process known as nonshivering thermogenesis, which is crucial in systemic energy homeostasis and thermoregulation. Functional brown and beige adipose tissues are highly correlated with body mass index in adult humans and is either reduced or absent in obese and aged individuals and rodents. The long-term research interest in the lab is to understand the regulation of white, beige and brown adipose tissue development and energy homeostasis, and use it to develop potential therapeutic approaches for obesity and related metabolic diseases.

Jose Mario is the Deputy Editor for Diabetes at the Community Forum of healthcare professionals in British Medical Journal. He is an Associate Professor in the Department of Medicine at Universidade Federal Fluminense, and a Senior Staff Physician in the Intensive Care Unit-Adults at Hospital Federal da Lagoa, all in Rio de Janeiro, Brazil. He also has been a principal investigator, and has published clinical studies & Letters to Editors about the mechanisms of cardiovascular diseases associated with type 2 diabetes mellitus in peer reviewed journals like British Medical Journal, Hypertension, New England Journal of Medcine, and American Journal of Hypertension. He was also a post-doctoral Clinical & Research Fellow in the Endocrinology-Diabetes and Hypertension Division of the Brigham & Women´s Hospital at Harvard Medical School where he did many angiotensin II infusions in humans, normotensive, hypertensive, and diabetic individuals. When at Harvard Medical School, he also became certified in the Principles of Epidemiology by the Harvard School of Public Health. He expect for the newer future better prevention and treatment strategies for macrovascular and microvascular diabetic complications, based on more rational and effective strategies. In the University, he is proud of running a busy Hypertension and type 2 diabetes clinic. At British Medical Journal, he enjoy the freedom and internationality of opinions. And also expect a brighter debate about all the clinical future research pathways and controversies surrounding diabetes mellitus.

He has a special interest in type 2 Diabetes, Preventive Cardiology, Hypertension, the renin-angiotensin-aldosterone system and Cardiovascular Diseases associated with Chronic Kidney Diseases.

Dr. Alessandro Antonelli (Associate Professor, MD) has completed his degree in Medicine, cum laude, in 1982, Specialization in Endocrinology in 1985, Specialization in Occupational Health in 1987, and Specialization in Oncology in 1992, at the University of Pisa, Pisa, Italy. He is now working as Associate Professor in the Department of Clinical and Experimental Medicine at the University of Pisa. His researches have been published in more than 280 articles on International journals (Impact Factor > 920, H-I=54). He serves as an Editorial Board Member and is Referee and Reviewer of many scientific international journals.

Endocrinology, Oncology, Occupational Health

Dr. Mandal is is board certified in Internal Medicine and Nephrology (Kidney disease and hypertension). He is an author of many books and published articles on research on diabetes and kidney disease. He is a two-times Fulbright Scholar and a visiting professor of 23 countries which permitted him to lecture on diabetes, high blood pressure and kidney diseases in all five continents of the world. Dr. Anil K. Mandal received Men and Women of Science in 1976, Who’s Who Frontiers in Science and Technology inFebruary 1983, Distinguished Visiting Professor, University of Belgrade, Yogoslavia in October 1985, Received the Fulbright Award 1992-1993 for India in December 20, 1991, Who’s Who in America in 1997, Distinguished Service Award by National Kidney Foundation Of the USA. Philadelphia, PA in October 22, 1998.

The research interest of Mandal is Sugar diabetes is the most common cause of kidney failure in the USA and world wide. This strong association between diabetes and kidney failure has inspired Dr Mandal to develop the frame work of Mandal Diabetes Research foundation to assist diabetic patients to live a good life with medical treatment, and not go to dialysis.

Dr. Adel Elnaggar is a medical endocrinologist with an extended expertise in adult diabetes and obesity; as regard prevention and early detection/diagnosis and management and risk reduction of their outcomes. He also share diabetes & obesity clinical trials link and research work concerning both. He is also leadership in community planning against chronic diseases/disabilities affecting community productivity; prevention & management. He is experienced in thyroid diseases and females endocrine health problems.

Diabetes,Obesity,Endocrinology and Psychological aspects of diabetes & obesity management

Deya’s research focuses on gene expression and function in the uterus and its relationship to fertility and cancer. Her clinical interests are Polycystic Ovary Syndrome (PCOS), endometriosis, unexplained infertility and gynaecological cancers (endometrial, ovarian and cervical cancer). She has strategic collaborations with clinicians at Abertawe Bro Morgannwg University NHS health board, developing cellular and molecular approaches to determine mechanisms underlying gynaecological pathologies, to identify biomarkers. Her projects on endometrial implantation and differentiation, relate to L-selectin ligands (MUC1), hormone nuclear receptors and WT1 pathway. Her research in gynaecological cancer includes the regulation of tamoxifen target genes in endometrium and new methods to identify biomarkers for pre-disposition of infertile women to develop gynaecological cancers. She leads an international research network (Prof. Rojas, Catholic University of Maule and Dr. Gracia, Director of Maule Clinic, Chile), studying protein glycation in relation to altered endometrial function. Her aim is to translate basic research into clinically relevant observations for patient benefit. Her projects involve collaboration with the private sector to expedite validation of clinical diagnostic biomarkers and the development of new drug leads for targeted cancer therapy. She also has multidisciplinary collaborations in the area of nanosensors and improved performance medications in the field of human reproductive biology and hormone therapy. She has received research grant valuing over £1m in the recent years. Deya has published more than 20 articles during her career on human, animal, plant and yeast research. She is a member of the Endocrine Society and acts as an expert reviewer for Journal of Clinical Endocrinology and Metabolism, Human Reproduction and others. She teaches within the Genetics & Biochemistry (College of Medicine) and Biomedical Engineering (College of Engineering) undergraduate programmes.

Endocrinology,Biochemistry

Guido Norbiato completed his MD at the age of 25 years from University of Studies in Milan-Italy. Postdoctoral studies , Specialty of Endocrinology and Metabolism, Qualification for University teaching, Assistant professor from the University of Studies of Milan. He moved to L.Sacco University Hospital of Milan where became Chief of the Endocrinology and Metabolism units and founded the Laboratory of Endocrinology, after he became Director of the Department of Specialistic Diseases. He published more than 140 articles and publications in internationally referred journals regarding endocrinology, metabolism, and autonomic, immune, inflammatory, vascular systems. Impact Factor 652. He edited two books on endocrinology and metabolism in HIV infection.

s

Emeritus Professor
University of Minnesota
USA
University of Minnesota
USA

CEO
Adeno Biosciences
USA
Adeno Biosciences
USA

Professor
University of Florida College of Medicine
USA
University of Florida College of Medicine, USA

Associate Professor
Texas Southern University
USA
Texas Southern University
USA

Chairman
Ipcheartcentre
USA
Ipcheartcentre
USA

Professor
King Abdulaziz University
Saudi Arabia
King Abdulaziz University
Saudi Arabia

Khaled A Alswat is an Assistant Professor of Medicine at Taif University and a Consultant physician of Endocrinology and Diabetes at King Abdulaziz Specialist Hospital, Tertiary and Referral Center in the Western Region, Saudi Arabia. With outstanding educational and research activities, he received his post-graduate training in Internal Medicine and Endocrinology from the George Washington University, Washington DC, USA. He is Certified Clinical Densitometrist by the International Society for Clinical Densitometry (ISCD).Active member of numerous Endocrine organizations. Actively participated in many Endocrine meetings including the Endocrine Society 2011&2012 meetings where some of his research was selected to be in the presidential session and amongst the top studies that received special mention in US media coverage.

Assistant Professor
Taif University School of Medicine
Saudi Arabia
Taif University School of Medicine, Saudi Arabia

Zhengyuan Xia had served as a cardiovascular anesthetist for more than 10 years in China before he completed his Ph.D study at the University of British Columbia, in Canada in 2004. He is now Assistant Professor and Honorary Associate Professor and Deputy Director, Anesthesiology Research Laboratory of the Department of Anesthesiology, University of Hong Kong. His major focus of research is post-ischemic cardiac protection in diabetes. He has published more than 96papers in reputed journals (such as Diabetes, Free Radical Biology & Medicine, Critical Care Medicine) and is serving as an Executive Editor of Journal of Diabetes & Metabolism.

Reactive oxygen species signalling in diabetic cardiomyophathy Antioxidant treatments for myocardial ischemia-reperfusion injury Pharmacological (anesthetic) preconditioning and postconditioning

Premanidhi panda has completed his M.B.B.S at the age of 24 years from Berhampur University, India and postdoctoral studies from Utkal University School of Medicine. He is the director of Dr. Panda Diabetes Institute,India, a premier Diabetes hospital cum research centre,India.He has worked in Tisco hospital, India, Benghazi medical(Libya), Medwin hospital with repute. He has been awarded as “India’s best doctor award:-2013(Diabetes)” by Medgate today survey. He has been awarded MRCP,FRCP BY Royal college of physician and surgeon of America in the year 2011. He has published more than 20 papers in reputed journals and serving as an editorial board member of repute. He has been awarded national & international awards for his contributions in diabetes.

Ceo
Dr. Panda Diabetes Centre
India
Dr. Panda Diabetes Centre, India

Professor
University of Hail
Saudi Arabia
University of Hail, Saudi Arabia

Lubov Kolesnikova completed her PhD in 1994 and became Corresponding member of Russian Academy of Medical Sciences in 2000 year. Since 1999 until present she is a director of Scientific сentre of family health and human reproduction problems of Siberian brunch of RAMS (Irkutsk, Russian Federation). She has published more than 400 papers and serving as an editorial board member of some journals.

Director
Russian Academy of Medical Sciences
Russia
Russian Academy of Medical Sciences, Russia

Professor
National Institute of Diabetes and Endocrinology
Egypt
National Institute of Diabetes and Endocrinology, Egypt

Hashim Mohamed is an Assistant Professor at Weill Cornell Medical College-Qatar and Senior Consultant Family Medicine in Doha, Qatar. His main interest is management of diabetic foot at primary care level .Dr Mohamed is an invited guest speaker at many local, regional and international conferences, the last one was "The fourth International Diabetic foot conference in Dubai" .He has published many papers with regards to the use of Natural Honey in the management of diabetic foot and recently wrote a chapter about the efficacy of natural honey in the management of diabetic foot ulceration. "Cellular and molecular mechanisms of honey wound healing"

Assistant Professor
Weil Cornell Medical College
Qatar
Weil Cornell Medical College, Qatar

Assistant Professor
Destiny University
UK
Ceo
Destiny University
UK

Judith Aponte is a Hispanic Nurse, Educator, Researcher and Speaker. She is a tenured Associate Professor at Hunter College, School of Nursing, City University of New York. Her research focus is on Hispanics with diabetes. She is a fellow at the Academy of Medicine. She was an awardee and finalist of the 2014 NY/NJ Nursing Excellence in Giving Excellence Meaning award in the category of Advancing and Leading the Profession. She has authored multiple peer-reviewed articles and has received grant funding, to examine diabetes and diabetes-related disparities among Hispanics and interventions that promote optimum health and minimize complications.

Diabetes is causing an increase in mortality and morbidity especially among Hispanics and integration of CHWs may improve and reduce diabetes-complications.

Fadi Nabhan has completed his MD at Damascus University and then Internal Medicine Residency and Endocrinology Fellowship at Loyola University Medical Center in Chicago. He is currently an Assistant Professor of Medicine at the Division of Endocirnolgy, Diabetes, and Metabolism at The Ohio State University in Columbus, OH in the USA . His research interest is in thyroid disease.

Endocrinology, Diabetes & Metabolism, Thyroid Diseases, Pancreatic Islets Transplantation

Pratiksha Gandhi is the chairperson of a Premier Preventive Cardiology Clinic in Mumbai (IPC Heart care). At IPC heart care, the emphasis is on prevention than intervention. We have treated thousands of patients using our proprietary prevention strategies.

Pratiksha Gandhi, Type-2 Diabetes, Diabetes expo 2015, LD-technologies, this non-invasive diagnostic technologies

Ayla Coussa has completed her degree in Dietetics & Human Nutrition at McGill University (Canada). She also obtained her Credentialed Practitioner Licence by the American Academy of Nutrition and Dietetics. She went on to complete a Master’s degree in Human Nutrition at McGill. Ms. Coussa is specialized in diabetes and weight-loss management. She was the first practitioner to introduce Nutrigenomix© genetic testing in Quebec (Canada). Ms. Coussa has also been involved in academia at McGill University at the School of Dietetics & Human Nutrition and the Faculty of Medecine. As an ongoing advocate of public wellbeing, Ms. Coussa plays a pioneer role in guidelines’ development and teaching practises for diabetes. She has developed the first Arabic version of the Diabetes Prevention and Management Nutrition tool for the Canadian Diabetes Association.

type 2 Diabetes, insulin resistance

A national expert in diabetes treatment whose studies of risk factors among Arab Americans are providing the first representative, population-based, cross-sectional estimates of diabetes incidence in this group.

Diabetes Mellitus, Blood glucose, Hypoglycemic agents

s

s

Johnny Ludvigsson, MD, PhD is a full Professor of Pediatrics, Linköping University. He performed the first immune intervention ever in T1D with plasmapheresis (BMJ 1983) which lead to the discovery of 64kD (Nature 1982), later shown to be GAD. He performed a number of different immune interventios both with GAD-alum (NEJM 2008, NEJM 2012) and AntiCD3 monoclonal antibodies (Lancet 2011). More than 430 scientific publications also on diabetic complications (NEJM 1994), and is the main tutor of >20 PhD students. He was the first pediatrician ever as Honorary member of EASD.

MC-insulin, Human insulin, Levemir, Novorapid, Humalog, Teplizumab, Diamyd

Abdelmarouf Hassan Mohieldein is an Associate Professor of Medical Biochemistry & Research Methodology, Department of Medical Laboratories, Qassim University. He was awarded Ph.D degree from Institute of Molecular Medicine, Moscow Medical Academy, Russia. He has got the training in chemical pathology, Newham General Hospital, London, U.K. He is a peer reviewer for several international journals and research funding agencies. He has 22 published papers in refereed journals. He authored the textbook of Medical Biochemistry. He participated in following international conferences (Moscow-Russia 2001, Cannes- France 2002, Brussels- Belgium 2003, Athens-Greece 2006, Nice-France 2009, and MarrakeshMorocco 2010). He has ongoing funded projects and supervising research students.

glucose tolerance, gestational diabetes mellitus, glycosylated hemoglobin

Mohsen Khalid has graduated from faculty of medicine Cairo University in November 1980. He has completed his Master degree in Internal Medicine May 1986, and then he completed his Medical Doctorate in Internal Medicine November 2003. He is a consultant of Diabetes and Endocrinology in the Egyptian National Institute of Diabetes and Endocrinology. He has published more than 20 papers in reputed journals. The research interest of Prof. Dr. Mohsen Khalid is Genetics of Diabetes, diabetic complications and how to assist diabetic patients to live a good life with life style modification and medical treatment.

Type 1 Diabetes Mellitus, Endocrinology, Genetics of Diabetes, diabetic complications

s

a

Zhengyuan Xia had served as a cardiovascular anesthetist for more than 10 years in China before he completed his Ph.D study at the University of British Columbia, in Canada in 2004. He is now Assistant Professor and Honorary Associate Professor and Deputy Director, Anesthesiology Research Laboratory of the Department of Anesthesiology, University of Hong Kong. His major focus of research is post-ischemic cardiac protection in diabetes. He has published more than 96papers in reputed journals (such as Diabetes, Free Radical Biology & Medicine, Critical Care Medicine) and is serving as an Executive Editor of Journal of Diabetes & Metabolism.

Reactive oxygen species signalling in diabetic cardiomyophathy
Antioxidant treatments for myocardial ischemia-reperfusion injury
Pharmacological (anesthetic) preconditioning and postconditioning

Fawzi holds a first class Bachelor in Science from the University of Mauritius, following which he secured the competitive Tertiary Education Commission postgraduate national scholarship to read for his MPhil/PhD in collaboration between University of Mauritius and TWAS-accredited H.E.J Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicines and Drug Research, Karachi, Pakistan. Following his initially appointment as a clinical studies manager for a private company, he has joined the Department of Health Sciences, Faculty of Science, University of Mauritius as a full time academic in 2009. He has recently been nominated as the TWAS-ROSSA Young Affiliates (2012-2016), recipent of the young promising scientist from Mauritius to attend the TWAS/BVA.NXT Biovision 2012 Egypt, selected amongt the top 40 young scientist to attend ‘Food Future’ conference in Italy and nominated as Young Ambassador to the American Society for Microbiology from 2013-2014.

q

h

b